Review of genetic risk variants in idiopathic pulmonary fibrosis among non-European individuals shows limited transferability.
One Gene Variant Drives Lung Scarring Across All Ancestries
This evaluation is a review focusing on idiopathic pulmonary fibrosis in clinically curated non-European individuals with limited sample siz…
A common gene switch that boosts lung mucus is the top risk factor for pulmonary fibrosis across all ancestries, guiding future testing.
Polygenic risk scores improve identification of rare variant carriers in idiopathic pulmonary fibrosis patients.
Can a genetic test help spot hidden lung disease risks in pulmonary fibrosis patients?
This observational cohort study of 888 IPF patients from the PFF-PR and 472 from the UK PROFILE cohort found that polygenic risk scores (PRS…
A genetic test helps doctors spot hidden disease risks in lung patients by finding rare gene variants that standard history alone might miss…
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs
FDA approves a new drug to treat two types of progressive, scarring lung diseases.
The FDA has approved nintedanib capsules for the treatment of adults with idiopathic pulmonary fibrosis (IPF) and for adults with chronic fi…
FDA approves new drug to treat two types of progressive, scarring lung diseases that make lungs stiff and hard to breathe.
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs
FDA approves a new drug to treat two serious, scarring lung diseases in adults.
The FDA has approved nintedanib capsules for the treatment of adults with idiopathic pulmonary fibrosis (IPF) and for adults with chronic fi…
FDA approves new drug nintedanib to treat two serious, scarring lung diseases in adults with progressive conditions.
U.S. workers' idiopathic pulmonary fibrosis mortality described by industry and occupation
Which jobs are linked to a deadly lung disease? A new report looks at U.S. workers.
An observational report described idiopathic pulmonary fibrosis deaths among U.S. workers by industry and occupation. The report did not pro…
A new report maps U.S. industries where deaths from a deadly lung disease called idiopathic pulmonary fibrosis are occurring.